CP-242 Bevacizumab in glioblastoma or anaplasic astrocytoma: effectiveness, safety and cost effectiveness analysis

    loading  Checking for direct PDF access through Ovid

Abstract

This abstract was published in error and withdrawn at the author’s request.

Related Topics

    loading  Loading Related Articles